Nearly 2.3 million individuals worldwide are coinfected with human immunodeficiency virus
(HIV) and hepatitis C virus (HCV). Odds of HCV infection are six times higher in people living …

Due to shared transmission routes, coinfection with Hepatitis C Virus (HCV) is common in
patients infected by Human Immunodeficiency Virus (HIV). The immunepathogenesis of …

Background There are several contributors to HIV-pathogenesis or insufficient control of the
infection. However, whether HIV/HCV-coinfected population exhibits worst evolution of HIV …

Reducing the incidence of hepatocellular carcinoma (HCC) in HIV-infected patients has
become a serious problem when managing these patients. There are many explanations for …

Hepatocellular carcinoma (HCC) accounts for approximately 80% of liver cancers, the third
most frequent cause of cancer mortality. The most prevalent risk factors for HCC are …

Despite their differential cell tropisms, HIV-1 and HCV dramatically influence disease
progression in coinfected patients. Macrophages are important target cells of HIV-1. We …

The role of HCV on the HIV reservoir is controversial since the reduction on HIV-DNA levels
after HCV eradication with IFNα/RBV treatment seems to be the result of drugs instead of …

Objective: To determine whether HIV-infected individuals versus individuals with HIV/HCV
coinfection, in the era of interferon-free therapies, exhibit an increased incidence of …

What are the factors that influence human hepatitis C virus (HCV) infection, hepatitis status
establishment, and disease progression? Firstly, one has to consider the genetic …

Even in the era of successful combination antiretroviral therapy (cART), co-infection of
Hepatitis C virus (HCV) remains one of the leading causes of non-AIDS-related mortality and …